HIPAA, PIPEDA and GDPR are not interchangeable privacy badges for an AI product. HIPAA is tied to defined health-sector actors and information in the United States, PIPEDA governs specified commercial handling of personal information in Canada, and GDPR applies to personal-data processing within its territorial and material scope.
Determine why each regime applies
Start with the parties and the feature, not the acronym. Identify the product company, customer, model provider, hosting provider and end user. Then record what each party decides about purpose and means. A contract calling a vendor secure does not determine the legal role, and a medical use case does not automatically make every participant subject to HIPAA.
For a United States health product, ask whether a covered entity or business associate relationship exists and whether protected health information enters the feature. HealthIT guidance can inform the inquiry, but qualified counsel should resolve uncertain status. Keep the conclusion tied to a named workflow instead of applying it to the entire company by default.
For Canada, examine the commercial activity, organization, province and flow of personal information. For the European Union, document territorial reach, controller and processor roles, purpose, lawful basis, data-subject rights and transfers. The same product may reach different conclusions for a clinic workspace, a consumer account and an anonymous demonstration.
Compare operational questions rather than labels
Build a matrix whose rows are product actions: account creation, prompt submission, model training, support access, analytics, export and deletion. Columns should capture the applicable regime, data category, role, disclosure, permission, retention, security measure, rights path and vendor term. Empty cells become visible decisions rather than hidden assumptions.
A medical-data security implementation note can help teams ask where sensitive information is isolated and monitored. Its title or reported experience is not certification for another product. Use it only as a prompt for architecture questions that must be answered with evidence from the system under review.
Reliable comparison also requires reproducible checks. The precision release record demonstrates how scoped tests support a bounded technical statement. Apply that discipline to privacy controls by testing the exact deletion path, access boundary and logging behavior described in the matrix.
Design for the strictest real constraint
Do not copy every obligation from every law into every feature. That creates confusing notices and controls without establishing compliance. Instead, find the strictest requirement that genuinely applies to the shared workflow, implement it as the baseline, and preserve justified market differences where roles or rights diverge.
Comparative context outside these three regimes can expose weak assumptions. The UAE website privacy risk discussion is not authority for North America or Europe, but it reinforces why teams should not reuse one regional notice without checking local rules and actual data collection.
Test the matrix against change. If the customer switches from a direct consumer product to a clinic deployment, roles and duties may shift even though the code is identical. The same applies when prompts begin supporting model improvement or when a new analytics provider receives identifiers. A comparison that cannot absorb those changes is only a static summary.
Assign an owner to every unresolved applicability question and prevent the affected feature from silently expanding while the answer is pending. Record the facts supplied to counsel, the conclusion received and the product configuration it covers. That history matters when a later team asks whether an earlier decision applies to a different customer or data source.
Frequently Asked Questions
No. Applicability depends on the entities, relationships and information involved, so a health use case alone is not enough.
No. A team must identify the proper lawful basis and meet the other duties that apply to the specific processing.
No. They have different legal structures and applicability tests even when operational controls may overlap.
It should produce a regime-by-feature matrix with data roles, purpose, disclosures, rights, vendor duties and unresolved questions.
The output should be a product decision package: applicability questions, role map, processing matrix, tested controls, contract gaps and legal issues requiring an answer. If the team only has a slide with three logos, it has not completed the comparison. A scoped AI governance and agent audit can examine whether the documented rules match product behavior.